Compare MINISO Group Holding Ltd (MNSO) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MINISO Group Holding Ltd vs TransMedics Group Inc — how do they compare? MINISO Group Holding Ltd trades at $11.93 (market cap $3.62B), while TransMedics Group Inc trades at $87.08 (market cap $3.10B). The key difference: MINISO Group Holding Ltd is the larger of the two by market cap, and MINISO Group Holding Ltd pays a 5.53% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| MNSO | TMDX | |
|---|---|---|
Market Cap | $3.62B | $3.10B |
Sector | Technology | Technology |
52-Week High | $26.63 | $150.42 |
52-Week Low | $11.30 | $61.99 |
Enterprise Value | $4.29B | $3.49B |
Dividend Yield | 5.53% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MNSO trades at $11.9, down 4.95% in the last session, with technical indicators showing a neutral to bearish bias. Recent earnings show volatility, with a Q1 2026 beat but prior misses, while fundamentals reveal solid revenue growth and improving profitability. The company announced a HK$2 billion share repurchase program in June 2026, signaling confidence.
The outlook is mixed: strong analyst buy ratings (75%) and undervalued metrics like a P/E of 12.16 support upside, but recent price declines and competitive pressures pose risks. Earnings consistency and margin sustainability are key for investor confidence.
TransMedics Group (TMDX) trades at $87.02, down 1.57% today, amid mixed signals. The stock shows a bullish technical trend with moving averages supporting upside, but oscillators like RSI indicate overbought conditions near 78. Fundamentally, the company reported record Q2 2026 revenue but missed earnings estimates, with net income margin declining to 22.69% from 31.42% in 2025. Recent news highlights an ongoing investigation into fiduciary duties by Rosen Law Firm, adding uncertainty.
The outlook remains cautiously optimistic with a consensus price target of $99.57, implying 14% upside, supported by strong analyst buy ratings (69%). However, risks include earnings volatility, margin pressure from rising costs, and legal scrutiny. Investors should weigh robust revenue growth against execution risks and elevated valuation multiples like a P/E of 23.15.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MINISO Group Holding Ltd
MINISO Group Holding Ltd is a global lifestyle product retailer known for its aesthetically pleasing, high-quality, and low-cost goods. The company operates a network of branded stores worldwide, offering a diverse range of merchandise, including household goods, cosmetics, toys, and digital accessories. MINISO's business model emphasizes rapid product iteration, efficient supply chain management, and a joint venture and franchise partner network to facilitate its global expansion.
Read more on MNSO →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
